News Chart Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2025-12-05 EST			5-day change	1st Jan Change
89.65 ^USD	+2.66%		-0.39%	+132.25%

12-06	Protagonist Therapeutics, Inc. and Takeda Pharmaceutical Company Limited Present Longer-Term Data At ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera	CI
11-06	Protagonist Therapeutics Q3 net loss widens to $39.3 mln	RE

dcc3b2060cb2b5f23c1.kj9e_TRBz7blJvsCnmC0Aze__suIcNceqgtG4hsKFEU._g4LiA0lofuDEbhqqQ78bVv2j6zfRud83UU-pytIIgbfbhCLeCC9h45zkA~0a0d2a099f4f66833f213d8189a25479